Biocompatible non-covalent complexes of chitosan and different polymers: characteristics and application in drug delivery
Clinical trials of semaglutide in people with type 2 diabetes show that while hypoglycemic events do occur, they are typically mild and manageable when doses of other medications are adjusted appropriately
This minimally invasive facial accelerates healing, reduces wrinkles and fine lines, diminishes acne scars, tightens pores, and improves overall skin texture and tone
It reports that by significantly increasing growth hormone receptor expression in tendon fibroblasts, BPC 157 may accelerate tissue repair and regeneration, offering hope for more effective treatments of tendon injuries
dose reductions of these agents may be necessary
The injectable semaglutide formulation demonstrated average weight reductions of 15% over 68 weeks in clinical trials